Dade Responds to Ortho/MLA Joint Venture
Executive Summary
In July 1994, J&J division Ortho Diagnostic Systems initiated a hematology joint venture with Medical Laboratory Automation to market MLA’s hemostasis instruments with Ortho’s hemostasis reagents, a big blow to Dade (then a subsidiary of Baxter), which for years had a similar arrangement with MLA. Now Dade has responded by signing a hematology partnership with Toa Medical Electronics.
You may also be interested in...
On the Verge of a Deal for Dade Behring
A year ago, Dade Behring, the nation's sixth largest diagnostics company, was facing a huge debt and very angry debt holders. Now, the company seems close to a deal that would allow it to cut the debt in half (to about $750 million) and give debtholders full ownership of Dade Behring. The company would file a voluntary pre-packaged bankruptcy in federal court, which would also enable it to start trading securities on the public equities market. Nothing is finalized, but sources say the company is confident it will prevail. Meanwhile, its financial performance is picking up, with strong growth in all core product lines.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.